Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
tvf8LF0A2ehnypUh